| POLAR CAPITAL BIOTECHNOLOGY I GBP DIS HEDGED | RVI BIOTECNOLOGÍA | 73,92% | 107,01% | 85,75% | · |
| BGF NEXT GENERATION TECHNOLOGY A2 SGD (HEDGED) | RVI TECNOLOGÍA | 73,89% | 127,14% | 33,75% | · |
| POLEN CAPITAL U.S. SMALL COMPANY GROWTH FUND USD A RETAIL CAP | RVI USA SMALL/MID CAP | 73,87% | 66,96% | 18,63% | · |
| BGF NEXT GENERATION TECHNOLOGY A2 GBP (HEDGED) | RVI TECNOLOGÍA | 73,77% | 139,80% | 27,86% | · |
| BGF NEXT GENERATION TECHNOLOGY Z2 CHF (HEDGED) | RVI TECNOLOGÍA | 73,66% | 138,33% | 42,92% | · |
| AB SICAV I-INTERNATIONAL TECHNOLOGY PORTFOLIO B USD | RVI TECNOLOGÍA | 73,62% | 155,92% | 113,97% | 692,22% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY V CAP USD | RVI BIOTECNOLOGÍA | 73,61% | 74,66% | 77,84% | 232,87% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY N CAP USD | RVI BIOTECNOLOGÍA | 73,60% | 70,50% | 72,77% | 207,07% |
| POLEN CAPITAL U.S. SMALL COMPANY GROWTH FUND USD C RETAIL CAP | RVI USA SMALL/MID CAP | 73,50% | 65,71% | 17,17% | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA EQUITY PORTFOLIO I SD USD DIS | RVI EMERGENTES | 73,45% | 98,23% | · | · |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP USD | RVI BIOTECNOLOGÍA | 73,42% | 74,07% | 76,79% | 228,66% |
| WELLINGTON ASIA TECHNOLOGY FUND N GBP ACC H | RVI TECNOLOGÍA | 73,40% | 148,80% | 84,27% | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA EQUITY PORTFOLIO I USD DIS | RVI EMERGENTES | 73,37% | 98,07% | · | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA EQUITY PORTFOLIO P USD CAP | RVI EMERGENTES | 73,37% | 99,83% | · | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA EQUITY PORTFOLIO R USD DIS | RVI EMERGENTES | 73,30% | 97,98% | · | · |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C DIS USD | RVI BIOTECNOLOGÍA | 73,28% | 69,36% | 71,16% | 201,71% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP EUR | RVI BIOTECNOLOGÍA | 73,28% | 72,94% | 76,75% | 229,92% |
| BGF NEXT GENERATION TECHNOLOGY S2 CHF (HEDGED) | RVI TECNOLOGÍA | 73,26% | 136,83% | 41,30% | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA EQUITY PORTFOLIO R GBP DIS | RVI EMERGENTES | 73,19% | 96,92% | · | · |
| PICTET - BIOTECH HR EUR | RVI BIOTECNOLOGÍA | 73,13% | 75,30% | 30,66% | 99,48% |
